Microarray-based analysis of spinal versus intracranial meningiomas: Different clinical, biological, and genetic characteristics associated with distinct patterns of gene expression

Journal of Neuropathology and Experimental Neurology

Volumn 65, Issue 5, 2006, Pages 445-454

  Sayagués, José María ^a   Tabernero, María Dolores ^b   Maíllo, Angel ^b   Trelles, Osvaldo ^c   Espinosa, Ana Belén ^a   Sarasquete, Maria Eugenia ^b   Merino, Marta ^b   Rasillo, Ana ^a   Vera, Jaime Fernandez ^a   Santos Briz, Angel ^b   De Alava, Enrique ^d   Garcia Macias, Maria Carmen ^e   Orfao, Alberto ^a,f  

^a UNIVERSITY OF SALAMANCA   (Spain)

^b HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^c UNIVERSITY OF MÁLAGA   (Spain)

^d Banco de Tumores   (Spain)

^e UNIVERSITY OF SALAMANCA   (Spain)

^f Centro de Investigacion del Cancer   (Spain)

Author keywords

FISH; Gene expression; Microarray; Spinal meningioma

Indexed keywords

ANIMAL TISSUE; ARTICLE; BIOLOGICAL TRAIT; CARCINOGENESIS; CELL CLONE; CHROMOSOME ABERRATION; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; GENETIC TRAIT; HUMAN; HUMAN CELL; INTRACRANIAL TUMOR; MAJOR CLINICAL STUDY; MICROARRAY ANALYSIS; MONOSOMY; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SPINAL CORD TUMOR; TRANSITIONAL CELL CARCINOMA; TUMOR DIFFERENTIATION; AGED; CLASSIFICATION; COMPARATIVE STUDY; DNA MICROARRAY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENETICS; MALE; MENINGIOMA; METABOLISM; METHODOLOGY; MIDDLE AGED; NONPARAMETRIC TEST; PATHOPHYSIOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

MESSENGER RNA;

AGED; CHROMOSOME ABERRATIONS; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STATISTICS, NONPARAMETRIC;

EID: 33746300579     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jnen.0000229234.13372.d8     Document Type: Article

References (47)

1. Kleihues P, Louis DN, Scheithauer BW, et al. The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 2002;61:215-25
2. Levy WJ, Bay J, Dohn D. Spinal cord meningioma. J Neurosurg 1982;57:804-12
3. Solero C, Fornari M, Giombini S, et al. Spinal meningiomas: Review of 174 operated cases. Neurosurgery 1989;25:153-60
4. Ciappetta P, Domenicucci M, Raco A. Spinal meningiomas: prognosis and recovery factors in 22 cases with severe motor deficits. Acta Neurol Scand 1988;77:27-30
5. Gezen Ferruh, Kahraman Serdar, Canakci Zafer, et al. Review of 36 cases of spinal cord meningioma. SPINE 2000;25:727-31
6. King AT, Sharr MM, Gullan RW, et al. Spinal meningiomas: a 20-year review. Br J Neurosurg 1998;12:521-26
7. Gottfried ON, Gluf W, Quinones-Hinojosa A, et al. Spinal meningiomas: Surgical management and outcome. Neurosurg Focus 2003;14:e2
8. Smith PJ, Wiltshire M, Davies S, et al. A novel cell permeant and far red-fluorescing DNA probe, DRAQ5, for blood cell discrimination by flow cytometry. J Immunol Methods 1999;229:131-39
9. Vindelov LL, Christensen IJ, Nissen NI. A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry 1983;3:323-27
10. Maillo A, Diaz P, Blanco A, et al. Proportion of S-phase tumor cells measured by flow cytometry is an independent prognostic factor in meningioma tumors. Cytometry 1999;38:118-23
11. Sayagués JM, Tabernero MD, Maillo A, et al. Incidence of numerical chromosome aberrations in meningioma tumors as revealed by fluorescence in situ hybridization (FISH) using 10 chromosome-specific probes. Clinical Cytometry 2002;50:153-59
12. Sayagués JM, Tabernero MD, Maillo A, et al. Intratumoral patterns of clonal evolution in meningiomas as defined by multicolor interphase fluorescence in situ hybridization (FISH): Is there a relationship between histopathologically benign and atypical/anaplastic lesions? J Mol Diag 2004;6:316-25
13. Garcia de la Nava J, van Hijum S, Trelles O. PreP: Gene expression data pre-processing. Bioinformatics 2003;19:2328-29
14. Mantle RE, Lach B, Delgado MR, et al. Predicting the probability of meningioma recurrence based on the quantity of peritumoral brain edema on computerized tomography scanning. J Neurosurg 1999;91:375-83
15. Zang KD, Singer H. Chromosomal consitution of meningiomas. Nature 1967;216:84-85
16. Zang KD. Cytological and cytogenetical studies on human meningioma. Cancer Genet Cytogenet 1982;6:249-74
17. Ketter R, Henn W, Niedermayer I, et al. Predictive value of progression-associated chromosomal aberrations for the prognosis of meningiomas: A retrospective study of 198 cases. J Neurosurg 2001;95:601-7
18. Cohen-Gadol AA, Zikel OM, Koch CA, et al. Spinal meningiomas in patients younger than 50 years of age: A 21-year experience. J Neurosurg 2003;98:258-63
19. Roux FX, Nataf F, Pinaudeau M, et al. Intraspinal meningiomas: review of 54 cases with discussion of poor prognosis factors and modern therapeutic management. Surg Neurol 1996;46:458-63
20. Leone PE, Bello MJ, de Campos JM. NF2 gene mutations and allelic status of 1p, 14q and 22q in sporadic meningiomas. Oncogene 1999;18:2231-39
21. Zattara-Cannoni H, Gambarelli D, Dufour H, et al. Contribution of cytogenetics and FISH in the diagnosis of meningiomas. A study of 189 tumors. Ann Genet 1998;41:164-75
22. Gutmann DH, Giordano MJ, Fishback AS, et al. Loss of merlin expression in sporadic meningiomas, ependymomas and schwannomas. Neurology 1997;49:267-70
23. Debiec-Rychter M, Biernat W, Zakrzewski K, et al. Loss of chromosome 22 and proliferative potential in ependymomas. Folia Neuropathol 2003;41:191-95
24. Hartmann C, Numann A, Mueller W, et al. Fine mapping of chromosome 22q tumor suppressor gene candidate regions in astrocytoma. Int J Cancer 2004;108:839-44
25. Antinheimo J, Sallinen SL, Sallinen P, et al. Genetic aberrations in sporadic and neurofibromatosis 2 (NF2)-associated schwannomas studied by comparative genomic hybridization (CGH). Acta Neurochir (Wien) 2000;142:1099-1104
26. Wharton SB, Wardle C, Ironside JW, et al. Comparative genomic hybridization and pathological findings in atypical teratoid/rhabdoid tumour of the central nervous system. Neuropathol Appl Neurobiol 2003;29:254-61
27. Lekanne PH, Deprez RH, Riegman E, et al. Cytogenetic, molecular genetic and pathological analyses in 126 meningiomas. J Neuropathol Exp Neurol 1995;54:224-35
28. Herzog R, Gottert E, Henn W. Large-scale physical mapping within the region 22q12.3-13.1 in meningioma. Genomics 1991;10:1041-46
29. Buschges R, Bostrom J, Wolter M, et al. Analysis of human meningiomas for aberrations of the MADH2, MADH4, APM-1 and DCC tumor suppressor genes on the long arm of chromosome 18. Int J Cancer 2001;92:551-54
30. Zhu JJ, Maruyama T, Jacoby LB, et al. Clonal analysis of a case of multiple meningiomas using multiple molecular genetic approaches: pathology case report. Neurosurgery 1999;45:409-16
31. Maruno M, Yoshimine T, Muhammad AK, et al. Chromosomal losses and gains in meningiomas: Comparative genomic hybridization (CGH) study of the whole genome. Neurol Res 1998;20:612-16
32. Arslantas A, Artan S, Oner U, et al. Detection of chromosomal imbalances in spinal meningiomas by comparative genomic hybridization. Neurol Med Chir (Tokyo) 2003;43:12-18
33. Jiang WG, Watkins G, Fodstad O, et al. Differential expression of the CCN family members Cyr61, CTGF and Nov in human breast cancer. Endocr Relat Cancer 2004;11:781-91
34. Mandl M, Slack DN, Keyse SM. Specific inactivation and nuclear anchoring of extracellular signal-regulated kinase 2 by the inducible dual-specificity protein phosphatase DUSP5. Mol Cell Biol 2005;25:1830-45
35. Gabriel B, Mildenberger S, Weisser CW, et al. Focal adhesion kinase interacts with the transcriptional coactivator FHL2 and both are overexpressed in epithelial ovarian cancer. Anticancer Res 2004;24:921-27
36. Pandya AY, Talley LI, Frost AR, et al. Nuclear localization of KLF4 is associated with an aggressive phenotype in early-stage breast cancer. Clin Cancer Res 20047;10:2709-19
37. Leaner VD, Kinoshita I, Birrer MJ. AP-1 complexes containing cJun and JunB cause cellular transformation of Rat1a fibroblasts and share transcriptional targets. Oncogene 2003;22:5619-29
38. Laux H, Tomer R, Mader MT, et al. Tumor-associated E-cadherin mutations do not induce Wnt target gene expression, but affect E-cadherin repressors. Lab Invest 2004;84:1372-86
39. Ueda K, Arakawa H, Nakamura Y. Dual-specificity phosphatase 5 (DUSP5) as a direct transcriptional target of tumor suppressor p53. Oncogene 2003;22:5586-91
40. Weber RG, Bostrom J, Wolter M, et al. Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: toward a genetic model of meningioma progression. Proc Natl Acad Sci U S A 1997;94:14719-24
41. Muller P, Henn W, Niedermayer I, et al. Deletion of chromosome 1p and loss of expression of alkaline phosphatase indicate progression of meningiomas. Clin Cancer Res 1999;5:3569-77
42. Chen X, Whitney EM, Gao SY, et al. Transcriptional profiling of Kruppel-like factor 4 reveals a function in cell cycle regulation and epithelial differentiation. J Mol Biol 2003;326:665-77
43. Brembeck FH, Rustgi AK. The tissue-dependent keratin 19 gene transcription is regulated by GKLF/KLF4 and Sp1. J Biol Chem 2000;275:28230-39
44. Sandberg AA. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: lipoma. Cancer Genet Cytogenet 2004;150:93-115
45. Carroll RS, Zhang J, Dashner K, et al. Androgen receptor expression in meningiomas. J Neurosurg 1995;82:453-60
46. Carroll RS, Glowacka D, Dashner K, et al. Progesterone receptor expression in meningiomas. Cancer Res 1993;53:1312-16
47. Roser F, Nakamura M, Bellinzona M, et al. The prognostic value of progesterone receptor status in meningiomas. J Clin Pathol 2004;57:1033-37